Patient id: (b)(6).It was reported that on (b)(6) 2022 two absolute pro (5x80, 5x40) stents were implanted in the heavily calcified, distal right superficial femoral artery.On (b)(6) 2023, there was restenosis of the stented segment.The patient was re-admitted to the hospital.Treatment consisted of percutaneous transluminal angioplasty with a drug coated balloon dilatation catheter and atherectomy.Another stent was implanted distal from the target study stent.No additional information was provided.
|
The device was not returned for evaluation.The reported patient effect of restenosis is listed in the absolute pro.035 peripheral self-expanding stent system instructions for use (ifu) as an adverse event that may be associated with the use of a stent in peripheral arteries and / or biliary tree.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|